GlaxoSmithKline (GSK.L) is to shed hundreds of U.S. commercial and research jobs, restructuring operations in its biggest market where drug sales are flagging. A total of 900 posts will be eliminated at GSK’s Research Triangle Park site in North Carolina as drug research is consolidated in Philadelphia and in Stevenage, near London, according to a … Continue reading
Global pharmaceutical and healthcare company GlaxoSmithKline (GSK) has reversed a decision to shut a plant run by one of its subsidiaries, saving over 100 jobs. The Stiefel facility in Co Sligo will remain open with an investment of €10m and initially retaining 120 of the 180 staff. It had been due to close next year… … Continue reading